Source: Annual Congress 2005 - Miscellaneous clinical problems



Rating:

Share or cite this content

Citations should be made in the following way:
J. Lalic, S. Stojiljkovic, I. Djordjevic, M. Radovic (Nis, Serbia And Montenegro). Diagnostic significance of lipid peroxidation products in differentiation of pleural effusions. Eur Respir J 2005; 26: Suppl. 49, 2043

Member's Comments

No comment yet.

Related content which might interest you: Lipid peroxidation products-diagnostic utility in differentation of pleural effusions Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Diagnostic usefulness of tumour markers in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Lipid peroxidation products-diagnostic utility in separation of exudates from transudates Source: Eur Respir J 2002; 20: Suppl. 38, 442s Year: 2002 Diagnostic yield of sl-selectin in differentiation of transudates from exudates in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007 Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008 Diagnostic value of amylase levels in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Diagnostic utility of biochemical parameters in patients with pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 Diagnostic value of lactatedehydrogenase in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002 Diagnostic significance of interferon-gamma level in tuberculous pleural effusions Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Evaluation of the utility of using pleural fluid cholesterol as a new criterion for the differential diagnosis between transudates and exudates Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Diagnostic efficiency of pleural fluid lipid-bound sialic acid level in malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002 Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Diagnostic value of leptin in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004 Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Diagnostic value of C-reactive protein in exudative pleural effusions Source: International Congress 2019 – Clinical problems Year: 2019 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Diagnostic implications of telomerase activity in pleural effusions Source: Eur Respir J 2004; 23: 653-654 Year: 2004 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010